OLIGOMERIX, Inc. is a biopharmaceutical company founded in 2006 located within the Audubon Biomedical Science and Technology Park of Columbia University. The Company is exploiting its novel research that allows rapid generation of stable amyloid...

Founded in 2006
Total money raised: $6.5M

New York
New York

Phone: (212) 568-0365

Updated on Nov 25, 2013
Oligomerix at CrunchBase
Vic Micati Chairman
Jack Pasini Director and CMO

September, 2013

Oligomerix raised $1.7M in grant round from National Institutes of Health (NIH)

Oligomerix obtains $1.7m NIH grant to develop small molecule drugs

May, 2013

Oligomerix raised $2.8M in a Series B round

Oligomerix Completes $2.8M Series B Financing

April, 2012

Oligomerix raised $2M in a Series A round from Durand Venture Associates, Wheatley MedTech Partners, and Wheatley New York Partners

Oligomerix Inks $2M


Oligomerix was founded in 2006